Japan's Ruling Party Proposes ¥20 Billion Funding To Support Biotech Venture Companies
This article was originally published in PharmAsia News
A policy team of Japan's ruling Liberal Democratic Party proposes establishing a fund to support biotech venture companies and accelerate new drug development. The ¥20 billion proposal, to be jointly funded by public and private sectors, is to select 10 companies and invest ¥2 billion in each. After the companies are profitable the fund will sell holding shares and benefit from the sales. Biotech veterans from university research facilities and pharmaceutical companies will select the candidates. (Click here for more - Japanese language) "LDP Proposes A ¥20 Billion Fund To Support Biotech Venture Companies" - Fuji Sankei Business News (6/17/08)
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
ClinROs, artificial intelligence-based algorithms will be included in approval pathway. FDA is taking a crash course on new techniques for trial assessment thanks to COVID.